Registration Dossier
Registration Dossier
Data platform availability banner - registered substances factsheets
Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.
The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.
Diss Factsheets
Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
Reaction mass of 1,4-bis(methylamino)anthraquinone and 1,4-bis[(2-ethylhexyl)amino]anthraquinone and 1-[(2-ethylhexyl)amino]-4-(methylamino)anthraquinone and 9,10-Anthracenedione, 1,4-bis(pentylamino)-, branched and linear and 9,10-Anthracenedione, 1-(methylamino)-4-(pentylamino)-, branched and linear and 9,10-Anthracenedione, 1-[(2-ethylhexyl)amino]-4-(pentylamino)-, branched and linear
EC number: 911-360-1 | CAS number: -
- Life Cycle description
- Uses advised against
- Endpoint summary
- Appearance / physical state / colour
- Melting point / freezing point
- Boiling point
- Density
- Particle size distribution (Granulometry)
- Vapour pressure
- Partition coefficient
- Water solubility
- Solubility in organic solvents / fat solubility
- Surface tension
- Flash point
- Auto flammability
- Flammability
- Explosiveness
- Oxidising properties
- Oxidation reduction potential
- Stability in organic solvents and identity of relevant degradation products
- Storage stability and reactivity towards container material
- Stability: thermal, sunlight, metals
- pH
- Dissociation constant
- Viscosity
- Additional physico-chemical information
- Additional physico-chemical properties of nanomaterials
- Nanomaterial agglomeration / aggregation
- Nanomaterial crystalline phase
- Nanomaterial crystallite and grain size
- Nanomaterial aspect ratio / shape
- Nanomaterial specific surface area
- Nanomaterial Zeta potential
- Nanomaterial surface chemistry
- Nanomaterial dustiness
- Nanomaterial porosity
- Nanomaterial pour density
- Nanomaterial photocatalytic activity
- Nanomaterial radical formation potential
- Nanomaterial catalytic activity
- Endpoint summary
- Stability
- Biodegradation
- Bioaccumulation
- Transport and distribution
- Environmental data
- Additional information on environmental fate and behaviour
- Ecotoxicological Summary
- Aquatic toxicity
- Endpoint summary
- Short-term toxicity to fish
- Long-term toxicity to fish
- Short-term toxicity to aquatic invertebrates
- Long-term toxicity to aquatic invertebrates
- Toxicity to aquatic algae and cyanobacteria
- Toxicity to aquatic plants other than algae
- Toxicity to microorganisms
- Endocrine disrupter testing in aquatic vertebrates – in vivo
- Toxicity to other aquatic organisms
- Sediment toxicity
- Terrestrial toxicity
- Biological effects monitoring
- Biotransformation and kinetics
- Additional ecotoxological information
- Toxicological Summary
- Toxicokinetics, metabolism and distribution
- Acute Toxicity
- Irritation / corrosion
- Sensitisation
- Repeated dose toxicity
- Genetic toxicity
- Carcinogenicity
- Toxicity to reproduction
- Specific investigations
- Exposure related observations in humans
- Toxic effects on livestock and pets
- Additional toxicological data
Endpoint summary
Administrative data
Description of key information
Reliable acute oral toxicity assay in rats.
Disregarded oral and dermal acute studies (rats and rabbits respectively)
Key value for chemical safety assessment
Acute toxicity: via oral route
Link to relevant study records
- Endpoint:
- acute toxicity: oral
- Type of information:
- experimental study
- Adequacy of study:
- key study
- Study period:
- 5-6-1982 to 5-20-1982
- Reliability:
- 2 (reliable with restrictions)
- Rationale for reliability incl. deficiencies:
- other: OECD guideline study performed in accordance with GLP; exact details of test material (certificate of analysis, Characterisation) are not included in the report.
- Qualifier:
- according to guideline
- Guideline:
- other: OECD Guidelines For Testing-of Chemicals, 1981
- Deviations:
- not specified
- GLP compliance:
- yes
- Test type:
- other:
- Limit test:
- no
- Species:
- rat
- Strain:
- Sprague-Dawley
- Sex:
- male/female
- Details on test animals or test system and environmental conditions:
- Five male and five female young adult Sprague-Dawley rats were purchased from Charles River Breeding Laboratories, Wilmington, MA. After an acclimation period of at least 5 days, animals were assigned to the test. Animals were individually housed in wire mesh bottom cages in environment controlled rooms as per "Guide for the Care and Use of Laboratory Animals" DREW Publication No. (NIH) 78-23.
Housing: Animals will be individually housed in wire mesh bottom cages When placed on study.
Food: NIH open formula 07, certified feed (Zeigler, Bro., Gardners, PA») ad libitum. No known cntaminants are expected to be present in the basal diet that would interfere with the conduct of this study.
Water: Tap water, ad libitum. Water is monitored for contaminants at periodic intervals according to FDRL Standard Operating Procedures.
Environment: All animals will be housed in environment controlled rooms as per "Guide for the Care and Use of Laboratory Animals". Filtered air will be supplied to provide 12-15 air changes per hour. A 12 hour light-dark cycle will be maintained.
Quarantine: Minimum of 5 days. During this conditioning period, the animals will be observed for any clinical signs of disease. All animals with any evidence of disease or physical abnormalities will be discarded. - Route of administration:
- oral: gavage
- Vehicle:
- corn oil
- Details on oral exposure:
- Dosing:
Animals were fasted overnight (approximately 18 hours) prior to receiving a single oral dose of 5.0g/kg of the test article. The test article was administered at a constant concentration and prepared just before use.
Concentration prepared: 50% w/v
Diluent: Corn Oil
Total amount dispensed: 40 ml
Prepared physical state: Solution - Doses:
- 5.0 g/kg body weight
- No. of animals per sex per dose:
- 5 male and 5 female per dose
- Control animals:
- no
- Details on study design:
- All animals were observed for at least 14 days or until all signs of reversible toxicity subsided, whichever occurred later. They were observed three times a day on the day of dosing and twice daily for the remainder of the study. Cageside observations included changes in the skin and fur, eyes and mucous membranes, and also respiratory, circulatory, autonomic and central nervous system, and somatomotor activity and behavior pattern. Particular attention was directed to observation of tremors, convulsions, salivation, diarrhea, lethargy sleeps and coma. All gross or visible toxic or pharmacological effects were recorded. Body weights were recorded initially and on days 8 and 15 or at death. All animals that died, and all survivors that were sacrificed at termination of the study were subjected to a gross necropsy. All abnormalities were recorded.
- Sex:
- male/female
- Dose descriptor:
- LD50
- Effect level:
- > 5 000 mg/kg bw
- Based on:
- test mat.
- 95% CL:
- 0 - 27
- Mortality:
- There was 0% mortality in the study.
- Clinical signs:
- other: Clinical observations: Males - Decreased activity in all 5 males. No deaths. Females - Decreased activity in all 5 females. Ataxia observed in all 5 females. No deaths.
- Gross pathology:
- Necropsy Observations:
Males - Fatty tissue and hypodermis appeared to have absorbed test article in all 5 males.
Females - Fatty tissue and hypodermis appeared to have absorbed test article in all 5 Females. - Interpretation of results:
- not classified
- Remarks:
- Migrated information Criteria used for interpretation of results: EU
- Conclusions:
- No mortality was observed in the treated rats. The acute oral LD50 of the test material was determined to be greater than 5.0g/kg body weight in male and female Sprague-Dawley rats.
- Executive summary:
An acute oral toxicity study was conducted using male and female Sprague-Dawley rats given a single oral dose of 5.0 g/kg body weight. No mortality was observed in the treated rats. Body weights increased in all animals during the study. Clinical observations included decreased activity in all animals as well as ataxia observed in all of the females. At necropsy, it was observed in all of the animals that the fatty tissue and hypodermis appeared to have absorbed the test article. The acute oral LD50 of the test material was determined to be greater than 5.0 g/kg body weight.
Reference
Bodyweight and Dosing Data
|
Body weight (g) at Day |
|
|
||
Animal number and sex |
1 |
8 |
15 |
Level Dosage g/kg |
Dose (ml) |
21 (M) |
319 |
348 |
370 |
5.0 |
3.19 |
22 (M) |
297 |
328 |
360 |
5.0 |
2.97 |
23 (M) |
322 |
356 |
378 |
5.0 |
3.22 |
24 (M) |
313 |
348 |
374 |
5.0 |
3.13 |
25 (M) |
310 |
330 |
344 |
5.0 |
3.10 |
26 (F) |
268 |
296 |
304 |
5.0 |
2.68 |
27 (F) |
230 |
250 |
258 |
5.0 |
2.30 |
28 (F) |
252 |
267 |
284 |
5.0 |
2.52 |
29 (F) |
220 |
233 |
238 |
5.0 |
2.20 |
30 (F) |
238 |
252 |
256 |
5.0 |
2.38 |
Endpoint conclusion
- Endpoint conclusion:
- no adverse effect observed
Acute toxicity: via inhalation route
Endpoint conclusion
- Endpoint conclusion:
- no study available
Acute toxicity: via dermal route
Endpoint conclusion
- Endpoint conclusion:
- no study available
Additional information
Acute oral toxicity:
An acute oral toxicity study was conducted using male and female Sprague-Dawley rats given a single oral dose of 5.0 g/kg body weight. No mortality was observed in the treated rats. Body weights increased in all animals during the study. Clinical observations included decreased activity in all animals as well as ataxia observed in all of the females. At necropsy, it was observed in all of the animals that the fatty tissue and hypodermis appeared to have absorbed the test article. The acute oral LD50 of the test material was determined to be greater than 5.0 g/kg body weight.
A second Oral acute toxicity study is available for this substance. However it was performed by Industrial Biotest at a time when there were known to be major concerns about fraudulent testing practices. In addition, the specific details of the substance tested (e.g. whether it contained only the registered substance or if it also contained solvent) are not clear from the limited report.. Consequently this study was disregarded and the more recent reliable study used as the key study. It should be noted that the results of this study do agree with the results from the key study, with the LD50 > 5g/kg bw.
Acute Dermal toxicity:
The only study available for this endpoint was performed by Industrial Biotest at a time when there were known to be major concerns about fraudulent testing practices. In addition, the specific details of the substance tested (e.g. whether it contained only the registered substance or if it also contained solvent) are not clear from the limited report. Consequently this study was disregarded. However, it should be noted that the LD50 was far in excess of 2 g/kg bw and given the low oral toxicity potential and limited dermal bioavailability (refer to TK section), a repeat of this study was not required.
Justification for classification or non-classification
Criteria for classification are not met.
Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.
Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.